Assessment of tumor growth factor‑β1 neutralizing antibody in the treatment of allergic rhinitis and asthma-Reference-Cited by-同舟云学术

Assessment of tumor growth factor‑β1 neutralizing antibody in the treatment of allergic rhinitis and asthma

Published:2017-11-13 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wei Yan¹,Zhang Zhili¹,Wang Feng¹,Zhou Shuihong¹

Affiliation:

1. Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital of The Medical School of Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations;Frontiers in Immunology;2024-04-02

2. TSLP Induces Epithelial–Mesenchymal Transition in Nasal Epithelial Cells From Allergic Rhinitis Patients Through TGF-β1/Smad2/3 Signaling;American Journal of Rhinology & Allergy;2023-08-03

3. Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts;International Journal of Molecular Sciences;2022-04-07

4. Sinomenine Relieves Airway Remodeling By Inhibiting Epithelial-Mesenchymal Transition Through Downregulating TGF-β1 and Smad3 Expression In Vitro and In Vivo;Frontiers in Immunology;2021-11-05

5. Alternatively activated macrophages; a double-edged sword in allergic asthma;Journal of Translational Medicine;2020-02-05